112
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Clinically Important Deterioration Among Patients with Chronic Obstructive Pulmonary Disease (COPD) Treated with Nebulized Glycopyrrolate: A Post Hoc Analysis of Pooled Data from Two Randomized, Double-Blind, Placebo-Controlled Studies

ORCID Icon, , &
Pages 2309-2318 | Published online: 29 Sep 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ling Lin, Qing Song, Wei Cheng, Cong Liu, Yi-Yang Zhao, Jia-Xi Duan, Jing Li, Dan Liu, Xin Li, Yan Chen, Shan Cai & Ping Chen. (2022) Comparation of predictive value of CAT and change in CAT in the short term for future exacerbation of chronic obstructive pulmonary disease. Annals of Medicine 54:1, pages 875-885.
Read now
Donald P Tashkin, Ayca Ozol-Godfrey, Sanjay Sharma & Shahin Sanjar. (2021) Effect of SGRQ-Defined Chronic Bronchitis at Baseline on Treatment Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 945-955.
Read now

Articles from other publishers (2)

Mario Cazzola & Maria Gabriella Matera. (2022) Clinically important deterioration: a composite tool for managing patients with COPD. Respiratory Medicine 205, pages 107054.
Crossref
Donald P. Tashkin, Xiaoli Niu, Sanjay Sharma & Shahin Sanjar. (2021) Impact of baseline clinical features on outcomes of nebulized glycopyrrolate therapy in COPD. npj Primary Care Respiratory Medicine 31:1.
Crossref